📰 ET Markets 🟢 BULLISH 🕒 02 Nov 2026, 08:34 PM IST

IPO-bound StockGro's profit jumps 3-fold to Rs 113 cr in FY26 on strong revenue growth

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: IPO-bound StockGro's profit jumps 3-fold to Rs 113 cr in FY26 on strong revenue growth

📊

Market & Financial Impact: In FY26, StockGro showcased substantial growth, achieving a profit after tax of Rs 112.96 crore while nearly doubling its revenue to Rs 226.14 crore, largely propelled by rising subscription fees. Operational costs increased, leading to higher total expenses. As the company gears up for an IPO, preliminary papers have been submitted to Sebi, with StockGro currently serving over 35 million users and capitalizing on India’s booming retail investment market.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Some elections matter more than you know: No crop changed in the fields, yet sugar, coffee and soya got cheaper in a day

You can buy a walkie-talkie online. But can you legally use it?

KYB and KYC: Quick commerce, the Damani premium and what DMart must deliver – 3rd and concluding part

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

IPO-bound StockGro's profit jumps 3-fold to Rs 113 cr in FY26 on strong revenue growth

🔥 More Live Market Stories

[DIGITIDE] ESOP/ESOS/ESPS - Digitide Solutions Limited

[NEPHROPLUS] Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - Nephrocare Health Services Limited

Vertex faces earnings test as kidney drugs near key milestones

[LLOYDSENGG] General Updates - LLOYDS ENGINEERING WORKS LIMITED

Shopify faces earnings test as AI shopping bet takes center stage

Major automakers urge US Congress to pass permanent ban on Chinese vehicles